Onderzoeker
Sileny Han
- Disciplines:Gynaecologie en verloskunde, Verpleegkunde, Endocrinologie en metabole ziekten
Affiliaties
- Departement Oncologie (Departement)
Lid
Vanaf1 okt 2017 → 10 jun 2018 - Gynaecologische Oncologie (Afdeling)
Lid
Vanaf1 aug 2010 → Heden
Projecten
1 - 2 of 2
- Sexualiteit en borstkankerVanaf1 okt 2020 → HedenFinanciering: VZW en equivalenten
- Seksualiteit bij borstkankerpatiëntenVanaf25 sep 2020 → HedenFinanciering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
11 - 20 van 102
- Real world adjuvant endocrine treatment in premenopausal breast cancer patients compared with the proposed algorithm using the Regan Composite Risk Score(2023)
Auteurs: Patrick Neven, Annouschka Laenen, Hans Wildiers, Ines Nevelsteen, Sileny Han, Eva Oldenburger, Christine Desmedt
- Correlation of TROP-2 expression with clinical-pathological characteristics and outcome in triple-negative breast cancer(2022)
Auteurs: Hava Izci, Annouschka Laenen, Hans Wildiers, Christine Desmedt, Ann Smeets, Sileny Han, Ines Nevelsteen, Patrick Neven, Beppe Floris
- Retrospective Cohort Study of Practical Applications of Paramagnetic Seed Localisation in Breast Carcinoma and Other Malignancies(2022)
Auteurs: Ines Nevelsteen, Chantal Van Ongeval, Patrick Neven, Sileny Han, Annouschka Laenen, Ann Smeets
- Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial(2022)
Auteurs: Sileny Han
Pagina's: 494 - 502 - Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial(2022)
Auteurs: Sileny Han
- Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry(2022)
Auteurs: Anne-Sophie Van Rompuy, Ignace Vergote, Sileny Han
Pagina's: 740 - 745 - Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer(2022)
Auteurs: Pieter Busschaert, Siel Olbrecht, An Coosemans, Wouter Froyman, Liselore Loverix, Els Van Nieuwenhuysen, Sileny Han, Toon Van Gorp, Tom Venken, Ruben Heremans, et al.
- Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer(2022)
Auteurs: Liselore Loverix, Pieter Busschaert, Els Van Nieuwenhuysen, Sileny Han, Siel Olbrecht, Patrick Neven, Diether Lambrechts, Toon Van Gorp, Ignace Vergote
Pagina's: 14 - 22 - Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-Method .(2022)
Auteurs: Sileny Han, Patrick Neven
Pagina's: 84 - 90 - TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma(2022)
Auteurs: Katrien De Clercq, Daniela Annibali, Frédéric Amant, Sileny Han, Els Van Nieuwenhuysen, Thaïs Baert, Karen Peeraer, Thomas Voets, Toon Van Gorp, Joris Vriens